Oral Treatment of Obesity by GLP-1 and Its Analogs
Obesity is a multifaceted disease that significantly increases the risk of various chronic conditions. GLP-1R (co)-agonists first emerged as therapeutics
A forum for researchers, students and applicants in the field of cyclodextrin technology
Obesity is a multifaceted disease that significantly increases the risk of various chronic conditions. GLP-1R (co)-agonists first emerged as therapeutics
The gut-joint axis is a bidirectional communication and interaction between the gastrointestinal tract (gut) and the joints. It involves the